Evidence map›Paper›PMID 41088113›Full record

ArticleBMC medical informatics and decision making2025

Machine learning model development and validation using SHAP: predicting 28-day mortality risk in pulmonary fibrosis patients.

Zijun Wu, Mingliang Li, Zhiliang Xu, Gang Liu

Abstract readValidation Study
In one paragraph

Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zijun Wu *Guangdong Medical University, No. 2 Wenming East Road, Xiashan District, Zhanjiang City, Guangdong Province, China.
Mingliang Li *Guangdong Medical University, No. 2 Wenming East Road, Xiashan District, Zhanjiang City, Guangdong Province, China.
Zhiliang XuAffiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Gang LiuGuangdong Medical University, No. 2 Wenming East Road, Xiashan District, Zhanjiang City, Guangdong Province, China. gangliu11@gdmu.edu.cn.

Funding

the National Natural Science Foundation of China 82070061
6 · The paper itself

Abstract

backgroundEarly prediction of mortality risk within 28 days of admission is crucial for personalized treatment in patients with pulmonary fibrosis (PF). This study aims to develop a predictive model for 28-day mortality risk in PF patients using interpretable machine learning (ML) methods.

methodsData from patients with pulmonary fibrosis were extracted from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. The study endpoint was mortality within 28 days of admission. Feature selection was performed using logistic regression and LASSO algorithms. Six machine learning algorithms-decision tree, k-nearest neighbors (KNN), LightGBM, single-hidden-layer neural network, support vector machine (SVM), and extreme gradient boosting (XGBoost)-were employed to construct risk prediction models. Additionally, SHapley Additive exPlanations (SHAP) were utilized to interpret the predictive models.

resultsAmong the six evaluated machine learning models, the LightGBM model demonstrated robust predictive performance, with an area under the receiver operating characteristic curve (AUC) of 0.819. SHAP analysis revealed that length of ICU stay, respiratory rate, and white blood cell count were the three most important features for predicting 28-day mortality risk in PF patients, with ICU stay duration having the most significant impact.

conclusionThis study indicates that machine learning methods hold potential for early prediction of mortality risk within 28 days of admission in patients with pulmonary fibrosis. Moreover, SHAP analysis enhanced the interpretability of the LightGBM model, thereby guiding clinical decision-making.

Indexed as

Machine LearningPulmonary FibrosisAgedFemaleHumansIntensive Care UnitsMaleMiddle AgedRisk AssessmentMachine learningPredictive modelPrognosisPulmonary fibrosis

Identifiers

PMID41088113
PMCPMC12522588

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.